News

manchempharma
manufacturingchemist. com > ofichem-consolidates-six-brands-single-integrated-cdmo-pharmaceutical

Ofichem consolidates six brands into single integrated CDMO and pharmaceutical supplier identity

4+ hour, 41+ min ago  (288+ words) Dutch family-owned pharmaceutical company Ofichem has unified its six business units " spanning API, drug substance, drug product and distribution " under a single trading name Ofichem has announced the consolidation of its brands "Ofichem BV, Ofipharma, Ofimedicine, Labatorium Ofichem, Ofichem Uppsala…...

manchempharma
manufacturingchemist. com > virica-biotech-fujifilm-biosciences-collaborate-aav-yields-hek293

Virica Biotech and FUJIFILM Biosciences collaborate to boost AAV vector yields in HEK293 manufacturing system

4+ hour, 16+ min ago  (361+ words) The pair will co-develop an off-the-shelf enhancer-media solution to boost AAV yields and "process robustness" in FUJIFILM Biosciences Balan CD HEK293 system. Virica added that it is receiving advisory services and funding from the National Research Council of Canada Industrial Research…...

manchempharma
manufacturingchemist. com > accelerating-the-development-of-bispecific-antibodies

Accelerating the development of bispecific antibodies

9+ hour, 6+ min ago  (147+ words) Sherry Gu, Executive Vice President and CTO at Wu Xi Biologics, explains how the use of comprehensive tailored approaches can enhance bispecific antibody productivity, stability and quality while accelerating their delivery to market Presenting new options for refractory cancers and…...

manchempharma
manufacturingchemist. com > uk-pharmaceutical-manufacturers-struggling-f-gas-compliance-cooling

UK pharmaceutical manufacturers struggling to meet F-Gas compliance amid ageing cooling infrastructure

1+ day, 4+ hour ago  (570+ words) A new Aggreko report reveals that nearly all UK pharmaceutical manufacturers are facing barriers to upgrading cooling systems ahead of the accelerating F-Gas phase-down timeline UK pharmaceutical manufacturers are under mounting pressure to comply with tightening F-Gas legislation, with ageing…...

manchempharma
manufacturingchemist. com > uk-reach-atrm-cba-welcomes-progress-warns-hurdles

UK REACH ATRm: CBA welcomes progress but warns of significant hurdles ahead

1+ day, 5+ hour ago  (447+ words) The Chemical Business Association has acknowledged long-awaited movement on the UK REACH Alternative Transitional Registration model following DEFRA's consultation response, but cautioned that cost burdens likely running into hundreds of millions of pounds The Chemical Business Association (CBA) has released…...

manchempharma
manufacturingchemist. com > lupin-completes-acquisition-visufarma-gho-ophthalmology-portfolio

Lupin completes acquisition of VISUfarma from GHO to expand ophthalmology portfolio

2+ day, 4+ hour ago  (273+ words) The addition enhances Lupin's presence in Europe and includes a portfolio of more than 60 innovative eye health products, backed by a well-established commercial infrastructure Lupin Limited has announced that it has completed the acquisition of European speciality pharmaceutical company, VISUfarma,…...

manchempharma
manufacturingchemist. com > swiss-rockets-collaborates-with-lonza-to-advance-torqur-s

Swiss Rockets collaborates with Lonza to advance Torqur's oncology drug candidate bimiralisib into late-stage clinical development

2+ day, 5+ hour ago  (517+ words) Manufacturing Chemist AK is a common pre-cancerous skin condition caused by chronic sun exposure and represents the leading precursor to cutaneous squamous cell carcinoma. Despite its prevalence, AK is frequently underdiagnosed, underscoring the need for effective therapeutic options. Bimiralisib is…...

manchempharma
manufacturingchemist. com > fda-approves-lilly-oral-glp-1-pill-foundayo-obesity

FDA approves Lilly's oral GLP-1 pill Foundayo for obesity with no food or water restrictions

6+ day, 9+ hour ago  (541+ words) Eli Lilly has received FDA approval for Foundayo (orforglipron), a once-daily oral GLP-1 receptor agonist for adults with obesity or overweight that requires no fasting or water restrictions, with clinical trial participants on the highest dose losing an average of…...

manchempharma
manufacturingchemist. com > tekpak-automation-to-showcase-pharma-pick-and-place

Tekpak Automation to showcase pharma pick-and-place robotic cell at interpack 2026

1+ week, 6+ hour ago  (195+ words) Tekpak Automation will demonstrate the benefits of robotics for pharmaceutical applications at interpack 2026, with a LIVE working demonstration of a 3-axis pick-and-place cell handling medipens on Stand A15/Hall 16 Tekpak is known for solving complex packaging line challenges with proven, modular…...

manchempharma
manufacturingchemist. com > saharsh-davuluri-to-take-over-as-ceo

Saharsh Davuluri to take over as CEO & MD of Neuland and lead the next phase of CDMO expansion

1+ week, 1+ hour ago  (240+ words) Announcement follows several years of stellar growth and points to a sharper focus on expanding commercial NCE opportunities Neuland Laboratories [NLL] (NSE: NEULANDLAB; BSE: 524558), a global contract development and manufacturing organisation (CDMO) specialising in complex APIs, has today announced a…...